LETICEA NEWTON: Open Payments
NPI 1265422281 · MUSKOGEE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 10 payments from 7 companies in 2025. Trend: 2023 $1,598 · 2024 $876 · 2025 $377
Food & beverage: $266Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $142 |
| Teva Pharmaceuticals USA, Inc. | 2 | $126 |
| Alkermes, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Indivior Inc. | 1 | $14 |
Products named: COBENFY, ARISTADA, REXULTI, INVEGA SUSTENNA, CAPLYTA, SUBLOCADE, AUSTEDO XR.
Industry payments across OK — which companies pay providers there.
